Clinical trial
Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy
NCT03177083
Study timeline
Study start (actual)2017-01-30Date precision: day
Registry last updated2020-11-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
peginterferon beta-1aDRUG · verified · RxNorm: peginterferon beta-1a
interferon beta-1aDRUG · verified · RxNorm: interferon beta-1a
interferon beta-1bDRUG · verified · RxNorm: interferon beta-1b
Sponsors & collaborators
Biogenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03177083 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.